mHealth Market Research Report- Global Forecast To 2027

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2027

ID: MRFR/HCIT/1284-HCR | February 2021 | Region: Global | 301 pages

Market Synopsis of mHealth Market


  Market Scenario


The global mHealth market is one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory workflow and the intense competitive rivalry among large number of public companies. Mobile health (mHealth) is also one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the increasing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. The various factors that influence the growth of mHealth market are patient’s involvement in personal healthcare, implementation of smartphones and wearable devices into healthcare industry, integration of wireless technologies with healthcare devices that are portable, benefits of Cost effectiveness and patients’ convenience and Increase in lifestyle diseases. Globally the market for mHealth is expected to grow at 36.5% CAGR (2016-2022).

mHealth market, by Region (%)




Key Players for mHealth Market
Some of the key players in this market are: Agamatrix, INC, Alivecor, INC, Apple, INC, Athenahealth INC, AT&T, INC, Biotelemetry INC. (CARDIONET), GE Healthcare, Google INC, Jawbone INC, Johnson & Johnson, Laboratory Corporation of America Holdings, Philips Healthcare and others.


Key Finding



  • The mHealth global market is expected to reach $ 21.71Billion by 2022.

  • Americas holds the largest market share of 34% of mHealth market globally.

  • Europe market is expected to grow at a CAGR of 35.65%.

  • Monitoring application segment hold 61.8% market share of global mHealth market by application.


 mHealth Market Segments      


mHealth market has been segmented on the basis of therapeutics which comprises of diabetes, respiratory, mental and neurological disorders, fitness & lifestyle therapeutics and others. Whereas on the basis of application the market is segmented into monitoring applications, diagnosis & treatment, education and awareness, healthcare management, wellness & prevention, remote data collection


Regional Analysis of mHealth Market                                                                      

Globally Americas is the largest market for mHealth market. The large size of the market can be attributed due to increasing digital advancement in medical technology. Asia-Pacific is the second-largest for mHealth market. Europe mHealth market is expected to grow with a steady pace.                         


North America

  • US

  • Canada


Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Europe


Asia

  • China

  • India

  • Japan

  • South Korea

  • Rest of Asia

  • Pacific


Latin America, Middle East & Africa

The report for mHealth market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.


Study Objectives of the Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the mHealth market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide forecast revenue of the market segments and sub-segments with respect to the main geography and various regions globally.

  • To provide regional level analysis of the market with respect to the current market size and future prospective

  • To provide regional level analysis of the market for segments by therapeutics, by application and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global mHealth market.


Intended Audience



  • MHealth companies

  • Hospitals and Dental Clinics

  • National Organizations & Government Organizations

  • Academic research institutes

  • Government institute



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2022- USD 21.71Billion
  • 2027: Significant Value
  •   CAGR   36.5% (2016-2022)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Therapeutics, Applications, End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Agamatrix, INC, Alivecor, INC, Apple, INC, Athenahealth INC, AT&T, INC, Biotelemetry INC. (CARDIONET), GE Healthcare, Google INC, Jawbone INC, Johnson & Johnson, Laboratory Corporation of America Holdings, Philips Healthcare and others.
      Key Market Opportunities    New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Patient’s involvement in personal healthcare
  • Implementation of smartphones and wearable devices into healthcare industry
  • Integration of wireless technologies with healthcare devices that are portable
  • Benefits of Cost effectiveness and patients’ convenience
  • Increase in lifestyle diseases


  • Frequently Asked Questions (FAQ) :


    The global mHealth market is expected to reach USD 21.71BN by 2022.

    The global mHealth market is expected to register a whopping CAGR over 34% throughout the assessment period (2016-2022).

    Implementation of smartphones and wearable devices into the healthcare industry.

    North America holds the largest share in the global mHealth market followed by Asia Pacific and Europe, respectively.

    Alivecor, INC, Agamatrix, INC, Apple, INC, AT&T, INC, Athenahealth INC, Biotelemetry INC. (CARDIONET), Google INC, GE Healthcare, Jawbone INC, Laboratory Corporation of America Holdings, Johnson & Johnson, and Philips Healthcare are some of the major players operating in the global mHealth market.

    1 REPORT SCOPE

    1.1 SCOPE OF THE STUDY

    1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE

    1.1.2 XX RESEARCH METHODOLOGY

    1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY

    1.1.3.1 Geographical Analysis

    1.1.3.2 Demand Side & Supply Side Analysis

    1.1.3.3 Data Synthesis & Bridging

    1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY

    1.1.5 KEY DATA POINT SOURCES

    1.1.5.1 Data Points taken from Secondary Sources

    1.1.5.2 Data Points taken from Primary Sources

    1.1.6 REPORT DESCRIPTION

    2 EXECUTIVE SUMMARY

    3 MARKET OVERVIEW

    3.1 INTRODUCTION

    3.2 MARKET DYNAMICS

    3.2.1 MARKET DRIVERS

    3.2.1.1 Patients Involvement in personal healthcare

    3.2.1.2 Proliferation of Smartphones and wearable devices into healthcare

    3.2.1.3 Integration of wireless technologies with portable healthcare devices

    3.2.1.4 Introduction of connected healthcare solutions in the mHealth market

    3.2.1.5 Benefits of Cost effectiveness and Patients’ Convenience

    3.2.1.6 Increase in Lifestyle Disease

    3.2.2 MARKET CHALLENGES

    3.2.2.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs)

    3.2.2.2 Invasion of Privacy

    3.2.2.2.1 Security Breach Cases

    3.2.2.2.2 Potential risk of Hardware or Software failure

    3.2.2.2.3 Stringent Regulations and Standards

    3.2.2.2.4 Lack of Awareness about the possible applications of mHealth

    3.2.3 MARKET OPPORTUNITIES

    3.2.3.1 Partnership: An entry mode

    3.2.3.2 Introduction of mHealth in developing economies

    4 INDUSTRY DYNAMICS

    4.1 MHEALTH MARKET TIMELINE

    4.2 VALUE CHAIN OF THE MHEALTH MARKET

    4.2.1.1 Device Manufacturers

    4.2.1.2 App Developers

    4.2.1.3 Network providers/ Mobile operators

    4.2.1.4 Healthcare providers and Pharmaceuticals

    4.2.1.5 Patients

    4.2.1.6 Consortiums, Certification, Regulations, & Standards

    4.2.1.6.1 Introduction

    4.2.1.6.2 Consortiums

    4.2.1.6.3 Alliance/Associations

    4.2.1.6.4 Regulatory Bodies

    4.2.1.7 Food and Drug Administration (FDA)

    4.2.1.8 Medical Device Regulation Act

    4.2.1.9 Medical Mobile Application(MMA)

    4.2.2 CERTIFICATION

    4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS

    4.2.4 BARGAINING POWER OF BUYER

    4.2.5 BARGAINING POWER OF SUPPLIER

    4.2.6 THREAT FROM SUBSTITUTE

    4.2.7 THREAT FROM A NEW ENTRANT

    4.2.8 INTENSITY OF COMPETITIVE RIVALRY

    5 GLOBAL MHEALTH MARKET ECOSYSTEM

    5.1 INTRODUCTION

    5.1.1 MHEALTH DEVICES

    5.1.2 MEDICAL DEVICES

    5.1.2.1 SMBG monitor

    5.1.2.1.1 SMBG Device Types& Uses

    5.1.2.1.2 Diseases Managed by SMBG Device

    5.1.2.1.3 Key players

    5.1.2.2 Blood Pressure (BP) Monitor

    5.1.2.2.1 BP Monitor Device Types & Uses

    5.1.2.2.2 Diseases Managed by BP Monitor Device

    5.1.2.2.3 Key players

    5.1.2.2.4 Pulse Oximeter

    5.1.2.2.5 Pulse Oximeter : Types & Uses

    5.1.2.2.6 Diseases Managed by Pulse Oximeter Device

    5.1.2.2.7 Key players

    5.1.2.3 Cardiac Monitors

    5.1.2.3.1 Diseases Managed by Cardiac Monitors

    5.1.2.3.2 Disease Management Devices Types

    5.1.2.3.3 Cardiac Monitor Uses

    5.1.2.4 Key players

    5.1.2.5 Other medical devices

    5.1.2.5.1 Health and Fitness Devices

    5.1.2.5.2 Hand Worn Products

    5.1.2.5.2.1 Smart Watch

    5.1.2.5.2.2 Wrist Wear

    5.1.2.5.3 Key players

    5.1.2.5.4 Head Worn Products

    5.1.2.5.4.1 AR/VR HMD/HUD

    5.1.2.5.4.2 Others

    5.1.2.5.4.3 Body worn products

    5.1.2.5.4.4 Smart Textile

    5.1.2.5.4.5 Wearable Patch

    5.1.2.5.4.6 Others

    5.1.2.5.5 Non-Clinical applications

    5.1.2.5.6 Clinical Application

    5.1.2.6 Others Devices

    5.1.2.6.1 Mobile telemedicine/tele-care devices

    5.1.2.6.2 Home care devices

    5.1.2.6.2.1 Vessyl

    5.1.2.6.2.2 TAO

    5.1.2.6.2.3 CubeSensors

    5.1.2.6.2.4 Kolibree

    5.1.2.6.2.5 TellSpec

    5.1.2.6.2.6 Kinsa

    5.1.2.6.2.7 Beddit

    5.1.2.6.2.8 Wello iPhone Case

    5.1.2.6.3 Key Participants

    5.1.2.7 mHealth Services

    5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION

    5.1.3.1 Software

    5.1.3.2 Big data

    5.1.3.3 Key Market Trends, Developments and Participants

    5.1.3.3.1 Market Trends and Market Developments

    5.1.3.3.2 Key Participants

    5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS

    5.1.4.1 Benefits of network & Services

    5.1.4.2 Key Market Trends, Developments and Participants

    5.1.4.2.1 Market Trends and Market Developments

    5.1.4.2.2 Key Participants

    5.1.5 HEALTHCARE AND PHARMACEUTICALS

    5.1.5.1 Healthcare providers

    5.1.5.2 Pharmaceuticals

    5.1.5.2.1 Key Market Trends, Developments and Participants

    5.1.5.2.1.1 Market Trends and Market Developments

    5.1.5.2.1.2 Key Participants

    6 GLOBAL MHEALTHMARKET – THERAPEUTICS

    6.1 INTRODUCTION

    6.1.1 GLOBAL MARKET STATISTICS

    6.1.1.1 Cardiovascular Diseases

    6.1.2 DEVICES

    6.1.3 APPS

    6.1.4 KEY PLAYERS

    6.2 DIABETES

    6.2.1 DEVICES

    6.2.2 APPS

    6.2.3 KEY PLAYERS

    6.3 RESPIRATORY

    6.3.1 DEVICES

    6.3.2 APPS

    6.3.3 KEY PLAYERS

    6.4 MENTAL AND NEUROLOGICAL DISORDERS

    6.4.1 DEVICES

    6.4.2 APPS

    6.4.3 KEY PLAYERS

    6.5 FITNESS & LIFESTYLE THERAPEUTICS

    6.5.1 DEVICES

    6.5.2 APPS

    6.5.3 KEY PLAYERS

    6.6 OTHERS

    7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE

    7.1 INTRODUCTION

    7.1.1 MONITORING APPLICATIONS

    7.1.1.1 Key Participants

    7.1.2 DIAGNOSIS & TREATMENT

    7.1.2.1 Key Participants

    7.1.3 EDUCATION AND AWARENESS

    7.1.3.1 Key Participants

    7.1.4 HEALTHCARE MANAGEMENT

    7.1.5 WELLNESS & PREVENTION

    7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET

    7.1.7 REMOTE DATA COLLECTION

    7.1.7.1 Key Market Developments

    8 GLOBAL MHEALTH MARKET–GEOGRAPHY

    8.1 INTRODUCTION

    8.1.1 MARKET STATISTICS

    8.1.2 THE AMERICAS

    8.1.3 NORTH AMERICA

    8.1.3.1 U.S.

    8.1.3.1.1 Key Market trends, Developments and Participants

    8.1.3.1.1.1 Key Market Trends and Developments

    8.1.3.1.1.2 Key Participants

    8.1.3.2 Canada

    8.1.3.2.1 Key Market Trend

    8.1.3.2.2 Key players

    8.1.3.3 South America

    8.1.3.3.1 Constraints

    8.1.3.3.2 Key Market Trends, Developments and Participants

    8.1.3.3.2.1 Market Trends and Market Developments

    8.1.3.3.2.2 Key Participants

    8.1.4 ASIA-PACIFIC (APAC)

    8.1.4.1 Key Drivers in APAC

    8.1.4.1.1 Key Market Trends, Developments and Participants

    8.1.4.1.1.1 Market Trends & Development

    8.1.4.1.1.2 Key Participants

    8.1.4.2 CHINA

    8.1.4.3 JAPAN

    8.1.4.4 AUSTRALIA

    8.1.4.5 INDIA

    8.1.5 EUROPE

    8.1.5.1 Key Market Trends, Developments and Participants

    8.1.5.2 The U.K.

    8.1.5.3 Germany

    8.1.5.4 Key Participants

    8.1.6 REST OF THE WORLD (ROW)

    8.1.6.1 Africa

    8.1.6.1.1 Key Market Trends, Developments and Participants

    8.1.6.1.1.1 Market Trends and Market Developments

    8.1.6.1.2 Key Participants

    8.1.7 MIDDLE EAST

    8.1.7.1 Key Market Trends, Developments and Participants

    8.1.7.1.1 Market Trends and Market Developments

    8.1.7.1.2 Key Participants

    9 KEY MARKET DEVELOPMENT AND STRATEGIES

    9.1 INTRODUCTION

    9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

    9.1.2 MERGERS & ACQUISITIONS

    9.1.3 PRODUCT DEVELOPMENT AND LAUNCH

    9.1.4 BUSINESS EXPANSION/CONTRACTS

    9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS

    9.1.6 OTHERS (EVENTS & RECOGNITIONS)

    10 COMPANY PROFILES

    1.1 AGAMATRIX, INC.

    10.1.1 OVERVIEW

    10.1.2 FINANCIALS

    10.1.3 KEY DEVELOPMENTS

    10.2 ALIVECOR, INC.

    10.2.1 OVERVIEW

    10.2.2 FINANCIALS

    10.2.3 KEY DEVELOPMENTS

    10.3 APPLE, INC.

    10.3.1 OVERVIEW

    10.3.2 FINANCIALS

    10.3.2.1 Overall Financials

    10.3.2.2 Financials By Segment

    10.3.2.3 Financials By Region

    10.3.2.4 Financial Summary

    10.3.3 KEY DEVELOPMENT

    10.4 ATHENAHEALTH INC.

    10.4.1 OVERVIEW

    10.4.2 FINANCIALS

    10.4.2.1 Overall Financials

    10.4.2.2 Financial by Segments

    10.4.2.3 Financial Summary

    10.4.3 KEY DEVELOPMENT

    10.5 AT&T, INC.

    10.5.1 OVERVIEW

    10.5.2 FINANCIALS

    10.5.2.1 Overall Financials

    10.5.2.2 Financials By Segment

    10.5.2.3 Financial Summary

    10.5.3 KEY DEVELOPMENTS

    10.6 BIOTELEMETRY, INC. (CARDIONET)

    10.6.1 OVERVIEW

    10.6.2 FINANCIALS

    10.6.2.1 Overall Financials

    10.6.2.2 Financials by Segment

    10.6.2.3 Financial Summary

    10.6.3 KEY DEVELOPMENTS

    10.7 GE HEALTHCARE

    10.7.1 OVERVIEW

    10.7.2 FINANCIALS

    10.7.2.1 Overall Financials

    10.7.2.2 Financials by Segment

    10.7.2.3 Financial Summary

    10.7.3 KEY DEVELOPMENTS

    10.8 GOOGLE INC.

    10.8.1 OVERVIEW

    10.8.2 FINANCIALS

    10.8.2.1 Financial Summary

    10.8.3 KEY DEVELOPMENTS

    10.9 JAWBONE, INC.

    10.9.1 OVERVIEW

    10.9.2 FINANCIALS

    10.9.3 KEY DEVELOPMENTS

    10.1 JOHNSON & JOHNSON

    10.10.1 OVERVIEW

    10.10.2 FINANCIALS

    10.10.2.1 Overall Financials

    10.10.2.2 Net Revenue By Segment

    10.10.2.3 Net revenue by Region

    10.10.3 KEY DEVELOPMENTS

    10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS

    10.11.1 OVERVIEW

    10.11.2 FINANCIALS

    10.11.2.1 Overall Financials

    10.11.2.2 Financials by Segment

    10.11.2.3 Financial Summary

    10.11.3 KEY DEVELOPMENTS

    10.12 MEDTRONIC PLC

    10.12.1 OVERVIEW

    10.12.2 FINANCIALS

    10.12.2.1 Overall Financials

    10.12.2.2 Financial Summary

    10.12.3 KEY DEVELOPMENTS

    10.13 NIKE INC.

    10.13.1 OVERVIEW

    10.13.2 FINANCIALS

    10.13.2.1 Overall Financials

    10.13.2.2 Financials by Segments

    10.13.2.3 Financial Summary

    10.13.3 KEY DEVELOPMENTS

    10.14 PFIZER

    10.14.1 OVERVIEW

    10.14.2 FINANCIALS

    10.14.2.1 Overall Financials

    10.14.2.2 Financials by Segment

    10.14.2.3 Financials By Region

    10.14.2.4 FINANCIAL SUMMARY

    10.14.3 KEY DEVELOPMENTS

    10.15 PHILIPS HEALTHCARE

    10.15.1 OVERVIEW

    10.15.2 FINANCIALS

    10.15.2.1 Overall Financials

    10.15.2.2 Financials By Region

    10.15.2.3 Financials By Segment

    10.15.2.4 Financial Summary

    10.15.3 KEY DEVELOPMENTS

    10.16 QUALCOMM, INC.

    10.16.1 OVERVIEW

    10.16.2 FINANCIALS

    10.16.2.1 Overall Financials

    10.16.2.2 Financials By Segment

    10.16.2.3 Financials By Region

    10.16.2.4 Financial Summary

    10.16.3 KEY DEVELOPMENTS

    10.17 QUEST DIAGNOSTICS INC.

    10.17.1 OVERVIEW

    10.17.2 FINANCIALS

    10.17.2.1 Overall Financials

    10.17.2.2 Financials by Segment

    10.17.2.3 Financial Summary

    10.17.3 KEY DEVELOPMENTS

    10.18 ROCHE HOLDING AG-BR

    10.18.1 OVERVIEW

    10.18.2 FINANCIALS

    10.18.2.1 Overall Financials

    10.18.2.2 Financials by Segment

    10.18.2.3 Financial Summary

    10.18.3 KEY DEVELOPMENTS

    10.19 SAMSUNG ELECTRONICS CO. LTD.

    10.19.1 OVERVIEW

    10.19.2 FINANCIALS

    10.19.2.1 Overall financials

    10.19.2.2 Financial Summary

    10.19.3 KEY DEVELOPMENTS

    10.2 SANOFI PHARMA

    10.20.1 OVERVIEW

    10.20.2 FINANCIALS

    10.20.2.1 Overall Financials

    10.20.3 FINANCIALS BY SEGMENT

    10.20.4 FINANCIAL SUMMARY

    10.20.5 KEY DEVELOPMENTS

    10.21 WITHINGS SAS

    10.21.1 OVERVIEW

    10.21.2 FINANCIALS

    10.21.3 KEY DEVELOPMENTS


    LIST OF TABLES


    TABLE 1L EADING COMPANIES IN THE MHEALTH MARKET

    TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2020-2027)

    TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS

    TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM

    TABLE 5 CONSORTIUMS IN MHEALTH MARKET

    TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET

    TABLE 7 REGULATORY BODIES IN MHEALTH MARKET

    TABLE 8 MHEALTH MARKET CERTIFICATIONS

    TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER

    TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER

    TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE

    TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT

    TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION

    TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2020-2027 ($MILLION)

    TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2020-2027 ($MILLION)

    TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2020-2027 ($MILLION)

    TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2027-2027 ($MILLION)

    TABLE 19 KEY DEVELOPMENTS

    TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS

    TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT

    TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 25 TYPE OF APP

    TABLE 26 KEY DEVELOPMENTS

    TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 29 KEY DEVELOPMENTS

    TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 42 REMOTE MONITORING IN GEOGRAPHIES

    TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2027-2027 ($MILLION)

    TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2027-2027 ($MILLION)

    TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES

    TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2027-2027 ($MILLION)

    TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES

    TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES

    TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES

    TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 62 MHEALTH: KEY DEVELOPMENTS (2020- 2027)

    TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)

    TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 67 THE U.S.: KEY DEVELOPMENTS

    TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2020-2027)

    TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 71 KEY DEVELOPMENTS IN APAC

    TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT

    TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)

    TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS (2020-2027)

    TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2020-2027)


    LIST OF FIGURES


    FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA

    FIGURE 2 XX RESEARCH METHODOLOGY

    FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET

    FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY

    FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2020-2027 ($MILLION)

    FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2020-2027 ($MILLION)

    FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2020-2027 ($MILLION)

    FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2020-2027 ($MILLION)

    FIGURE 9 MARKET DRIVERS AND CHALLENGES

    FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS

    FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS

    FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS

    FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS

    FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS

    FIGURE 15 VALUE CHAIN

    FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS

    FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES

    FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS

    FIGURE 19 MHEALTH ECOSYSTEM

    FIGURE 20 TYPE OF MHEALTH DEVICES

    FIGURE 21 SMBD DEVICE USES

    FIGURE 22 USES OF BP MONITORING DEVICE

    FIGURE 23 PULSE OXIMETER USES

    FIGURE 24 WEARABLE DEVICE COMPONENTS

    FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES

    FIGURE 26 HAND WORN MHEALTH DEVICES

    FIGURE 27 APPLE WATCH FIGURE

    FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS

    FIGURE 29 GOOGLE’S CONTACT LENS

    FIGURE 30 HEAD WORN DEVICES

    FIGURE 31 ELECTRONIC FINGERTIP

    FIGURE 32 COMPONENTS OF BIOSTAMP

    FIGURE 33 MYO ARMBAND BY THALMIC LABS

    FIGURE 34 NON-CLINICAL BENEFITS

    FIGURE 35 WEARABLE MEDICAL DEVICES

    FIGURE 36 FITNESS TRACKING DEVICES

    FIGURE 37 TYPES OF MHEALTH SERVICES

    FIGURE 38 TYPES OF APPS

    FIGURE 39 BENEFITS OF BIG DATA

    FIGURE 40 BENEFITS OF NETWORK & SERVICES

    FIGURE 41 ROLES OF MOBILE OPERATORS

    FIGURE 42 ROLE OF HEALTHCARE PROVIDERS

    FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS

    FIGURE 44 BENEFITS OF MHEALTH IN CVDS

    FIGURE 45 BENEFITS OF MHEALTH

    FIGURE 46 BENEFITS OF MHEALTH

    FIGURE 47 BENEFITS OF MHEALTH

    FIGURE 48 BENEFITS OF MHEALTH

    FIGURE 49 TYPES OF MHEALTH APPLICATION

    FIGURE 50 ADVANTAGES OF REMOTE MONITORING

    FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES

    FIGURE 52 EDUCATION & AWARENESS SERVICES

    FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT

    FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY

    FIGURE 55 APAC: MARKET DRIVERS

    FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2020)

    FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS (2020)

    FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2020)

    FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2020)

    FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS (2020)

    FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2020-2027

    FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2020-2027

    FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2020-2027 ($MILLION)

    FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2020-2027

    FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027

    FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2020-2027

    FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027

    FIGURE 72 GE HEALTHCARE SEGMENT, 2027

    FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2020 - 2027 ($BILLION)

    FIGURE 74 J&J: OVERALL FINANCIALS, 2020 - 2027 ($ BILLION)

    FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2020-2027

    FIGURE 76 NET REVENUE BY SEGMENTS, 2020-2027

    FIGURE 77 NIKE: OVERALL FINANCIALS 2020 - 2027 ($BILLION)

    FIGURE 78 NIKE: REVENUE BY REGION (2020-2027)

    FIGURE 79 PFIZER: OVERALL FINANCIALS, 2020-2027 ($BILLION)

    FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 81 PFIZER: FINANCIALS BY REGION, 2020-2027 ($BILLION)

    FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2020-2027 ($MILLION)

    FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2020-2027 ($MILLION)

    FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2020-2027 ($BILLION)

    FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2020-2027 ($MILLION)

    FIGURE 88 QUEST: OVERALL FINANCIALS, 2020-2027 ($MILLION)

    FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2020-2027 ($MILLION)

    FIGURE 90 ROCHE: OVERALL FINANCIALS, 2020-2027 ($BILLION)

    FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2020-2027 ($BILLION)

    FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2020-2027